Dr. Bristol Brandt Whiles, MD

Dr. Whiles practices at University Health Truman Medical Center in Kansas City, Missouri, part of University Health.

Dr. Whiles' NPI, 1932632072, was assigned on April 5, 2017. Dr. Whiles graduated from University of Kansas School of Med (KC/Wich/Sal) in 2017. Dr. Whiles holds Florida license ME155054.

Dr. Whiles' primary practice is University Health Truman Medical Center, at 2301 Holmes Street, Kansas City, MO 64108 in Jackson County. The practice phone is (816) 404-1000.

Dr. Whiles' primary practice is University Health Truman Medical Center in Kansas City, Missouri, part of University Health. Dr. Whiles is also affiliated with The University of Kansas Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Whiles to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Whiles practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Whiles' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Whiles is licensed in Florida.

CMS data shows 437 Medicare services from Dr. Whiles across 17 procedure codes in 2024, for 200 Medicare patients. Medicare paid $53,514 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 200 Medicare patients who saw Dr. Whiles in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Whiles' median patient age at 66, with 33% women.

In 2024, Dr. Whiles wrote 185 Medicare Part D claims for 95 patients. 86% of them were for generic drugs. CMS names the drug for 99 of them, across 5 drugs with 11 or more claims each, at $13,988 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Whiles for performance year 2024, reported through an alternative payment model (APM). Dr. Whiles accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Whiles as offering telehealth. CMS counts 27 procedures of prostate resection by Dr. Whiles, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Whiles, published from 2019 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Kidney Calculi, Urology and Nephrolithotomy, Percutaneous. Dr. Whiles has published most often in World J Urol. Dr. Whiles' most frequent co-authors are David A. Duchene, MD, Donald A. Neff, MD and Vincent Gerard Bird, MD.

CMS Open Payments shows 129 general payments to Dr. Whiles from 10 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 44% of the total. Boston Scientific Corporation paid the most, $84,057.

Dr. Whiles graduated from University of Kansas School of Med (KC/Wich/Sal) in 2017.